| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16.0M | -1.7% | +25.5% |
| Cost of Revenue | $11.2M | -3.5% | +14.0% |
| Gross Profit | $4.7M | +2.8% | +65.0% |
| R&D Expense | $585K | -15.5% | -64.1% |
| SG&A Expense | $5.3M | +14.7% | +21.5% |
| Operating Income | -$3.8M | -15.1% | +37.3% |
| Pre-tax Income | -$11.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.8M | +40.4% | -52.1% |
| Accounts Receivable | $4.8M | +34.3% | +28.6% |
| Inventory | $22.7M | +7.9% | -5.4% |
| Current Assets | $34.5M | +12.1% | -12.3% |
| Total Assets | $73.8M | +2.9% | -12.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$11.2M | — | — |
| Capital Expenditures | $1.8M | — | — |
| Investing Cash Flow | -$1.8M | — | — |
| Financing Cash Flow | $12.0M | — | — |
| Free Cash Flow | -$13.1M | — | — |
| -57.4% |
| -63.3% |
| Net Income | -$11.1M | -57.4% | -63.3% |
| EPS (Basic) | -$0.20 | +65.5% | -81.8% |
| EPS (Diluted) | -$0.20 | +65.5% | -81.8% |
| $25.7M |
| +14.6% |
| -47.9% |
| Long-term Debt | $97.1M | +4.2% | +17.8% |
| Total Liabilities | $95.4M | +9.5% | +13.4% |
| Stockholders' Equity | -$21.6M | -30.0% | -7165.0% |